Example: Heart Attack

Clinical Trials on Recurrent Angiosarcoma

Total 7977 results

NCT05026736

Terminated

Sintilimab for the Treatment of Locally Advanced, Metastatic, or Recurrent Angiosarcoma, the SiARa Cancer Study

Locally Advanced Angiosarcoma | Metastatic Angiosarcoma | Recurrent Angiosarcoma
NCT04668300

Active, not recruiting

Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma (DOSa)

Recurrent Osteosarcoma | Refractory Osteosarcoma | Metastatic Osteosarcoma | Metastatic Angiosarcoma | Recurrent Dedifferentiated Liposarcoma | Metastatic Dedifferentiated Liposarcoma | Recurrent Angiosarcoma | Refractory Dedifferentiated Liposarcoma
NCT01055028

Terminated

Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable Angiosarcoma

Soft Tissue Sarcoma | Angiosarcomas
NCT04339738

Active, not recruiting

Testing the Addition of Nivolumab to Chemotherapy in Treatment of Soft Tissue Sarcoma

Skin Angiosarcoma | Skin Radiation-Related Angiosarcoma | Visceral Angiosarcoma
NCT07655570

Recruiting

Pilot Study of Ivonescimab in Advanced/Metastatic Cutaneous Angiosarcoma

Cutaneous Angiosarcoma

This is a preview
Log in or create a free account to see all matching trials and use the full search.
Log in | Register